Home Your basket
• Cytokines profile in cyst...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• A non-linear model of lar...
   Price 10.50 €
• Blepharoplasty and upper ...
   Price 10.50 €
• Interventional phoniatry...
   Price 14.00 €
• Is ethmoidal adenocarcino...
   Price 10.50 €
• Long term results of KTP ...
   Price 5.50 €
• Osteoid osteomas in the f...
   Price 5.50 €
• Acceptability of topical ...
   Price 5.50 €
• Melanotic neuroectodermal...
   Price 8.50 €
• Cochlear implantation in ...
   Price 14.00 €
• Clinico-radiological cons...
   Price 10.50 €
• A specific plain X-ray in...
   Price 8.50 €
• Hearing preservation in p...
   Price 10.50 €
• Acquired non tumoral lary...
   Price 12.00 €
• Karapandzic flap for reco...
   Price 10.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Is HIV/AIDS an independen...
   Price 10.50 €
• Human skull development a...
   Price 10.50 €
• Importance of a molding n...
   Price 10.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Functional anatomy of the...
   Price 14.00 €
• Parathyroïd adenoma induc...
   Price 8.50 €
• Acinic cell carcinoma in ...
   Price 8.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Laryngeal tracheal post-i...
   Price 8.50 €
• Scaling properties of the...
   Price 5.50 €
• Social consequence of a d...
   Price 10.50 €
• Intra oral approach versu...
   Price 12.00 €
• Voice after supracricoid ...
   Price 10.50 €
• The effects of treatments...
   Price 14.00 €
• Bilateral cleft lip and c...
   Price 14.00 €
• Periphery, central and ps...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• The Bell Labs contributio...
   Price 12.50 €

Total Order 360.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE